My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.

    Zacharewski T.

    Environ Health Perspect. 1998 Apr;106 Suppl 2:577-82. Review.PMID: 9599705 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Endocrine disrupters--testing strategies to assess human hazard.

    Baker VA.

    Toxicol In Vitro. 2001 Aug-Oct;15(4-5):413-9. Review.PMID: 11566572 [PubMed - indexed for MEDLINE]Related articles

    3.

    Endocrine active agents: implications of adverse and non-adverse changes.

    Foster PM, McIntyre BS.

    Toxicol Pathol. 2002 Jan-Feb;30(1):59-65.PMID: 11892727 [PubMed - indexed for MEDLINE]Related articles

    4.

    Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.

    Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, Foster PM, Gray CL, Gray LE.

    Toxicol Sci. 2008 Oct;105(2):235-59. Epub 2008 Feb 16. Review.PMID: 18281716 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).

    O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW.

    Crit Rev Toxicol. 2002;32(6):521-49. Review.PMID: 12487364 [PubMed - indexed for MEDLINE]Related articles

    6.

    The endocrine and reproductive system: adverse effects of hormonally active substances?

    Greim HA.

    Pediatrics. 2004 Apr;113(4 Suppl):1070-5.PMID: 15060201 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.

    Naciff JM, Daston GP.

    Toxicol Pathol. 2004 Jul-Aug;32 Suppl 2:59-70. Review.PMID: 15503665 [PubMed - indexed for MEDLINE]Related articles

    8.

    Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.

    Dent MP.

    Regul Toxicol Pharmacol. 2007 Aug;48(3):241-58. Epub 2007 Apr 12.PMID: 17512650 [PubMed - indexed for MEDLINE]Related articles

    9.

    Environmental exposures that affect the endocrine system: public health implications.

    DeRosa C, Richter P, Pohl H, Jones DE.

    J Toxicol Environ Health B Crit Rev. 1998 Jan-Mar;1(1):3-26. Review.PMID: 9487091 [PubMed - indexed for MEDLINE]Related articles

    10.

    Endocrine toxicology--contributions of in vitro methods to the 3R concept.

    Freyberger A, Scholz G.

    ALTEX. 2004;21 Suppl 3:20-7.PMID: 15057405 [PubMed - indexed for MEDLINE]Related articles

    11.

    OECD test strategies and methods for endocrine disruptors.

    Gelbke HP, Kayser M, Poole A.

    Toxicology. 2004 Dec 1;205(1-2):17-25. Review.PMID: 15458786 [PubMed - indexed for MEDLINE]Related articles

    12.

    Validation of in vitro and in vivo methods for assessing endocrine disrupting chemicals.

    Ashby J.

    Toxicol Pathol. 2000 May-Jun;28(3):432-7. Review.PMID: 10862561 [PubMed - indexed for MEDLINE]Related articles

    13.

    Development of a Tier I screening battery for detecting endocrine-active compounds (EACs).

    Cook JC, Kaplan MA, Davis LG, O'Connor JC.

    Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):60-8.PMID: 9339481 [PubMed - indexed for MEDLINE]Related articles

    14.

    Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing.

    Kroes R, Galli C, Munro I, Schilter B, Tran L, Walker R, Würtzen G.

    Food Chem Toxicol. 2000 Feb-Mar;38(2-3):255-312. Review.PMID: 10717364 [PubMed - indexed for MEDLINE]Related articles

    15.

    The case for taking account of metabolism when testing for potential endocrine disruptors in vitro.

    Combes RD.

    Altern Lab Anim. 2004 Jun;32(2):121-35. Review.PMID: 15601241 [PubMed - indexed for MEDLINE]Related articles

    16.

    Endocrine disruptors: can biological effects and environmental risks be predicted?

    Witorsch RJ.

    Regul Toxicol Pharmacol. 2002 Aug;36(1):118-30. Review.PMID: 12383724 [PubMed - indexed for MEDLINE]Related articles

    17.

    The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: critical omissions from regulatory endocrine disrupter screening strategies for human health?

    Harvey PW, Everett DJ.

    J Appl Toxicol. 2003 Mar-Apr;23(2):81-7. Review.PMID: 12666151 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adequacy of required regulatory hazard testing for the detection of potential hormonal activity of crop protection chemicals.

    Stevens JT, Gfeller W, Machemer L, Leist KH.

    J Toxicol Environ Health B Crit Rev. 1998 Jan-Mar;1(1):59-79. Review.PMID: 9487093 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of the laboratory rat as a model in endocrine disruptor screening and testing.

    Gray LE Jr, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PM.

    ILAR J. 2004;45(4):425-37. Review.PMID: 15454681 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies.

    Stokes WS.

    ILAR J. 2004;45(4):387-93. Review.PMID: 15454677 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity